top of page

HOME > 論文実績 >

免疫/膠原病/感染症

​論文実績

絞り込み:

免疫/膠原病/感染症

596

Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan

​発表年月

Mar-23

Therapeutic area
免疫/膠原病/感染症
Immunology/Infectious disease

589

Risk of infection from glucocorticoid and methotrexate interaction in patients with rheumatoid arthritis using biologics: A retrospective cohort study

​発表年月

Feb-23

Therapeutic area
免疫/膠原病/感染症
Immunology/Infectious disease

582

Computational Simulation Model to Predict Behavior Changes in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Analysis of Two Regional Japanese Populations

​発表年月

Jan-23

Therapeutic area
免疫/膠原病/感染症
Immunology/Infectious disease

566

Annual prevalence of non-communicable diseases and identification of vulnerable populations following the Fukushima disaster and COVID-19 pandemic

​発表年月

Nov-22

Therapeutic area
免疫/膠原病/感染症
Immunology/Infectious disease

565

4. Early Post-marketing Phase Vigilance and Post-marketing Survey of SARS‒CoV‒2 Vaccine Under COVID‒19 Situation

​発表年月

Nov-22

Therapeutic area
免疫/膠原病/感染症
Immunology/Infectious disease

557

Performing colonoscopy before steroid induction is associated with shorter steroid use in patients with ulcerative colitis

​発表年月

Dec-22

Therapeutic area
免疫/膠原病/感染症
Immunology/Infectious disease

555

Treatment Patterns in Newly Diagnosed Patients with Crohn's Disease Who Received Biologics Following Diagnosis: A Nationwide, Retrospective, Longitudinal, Observational Study Using a Medical Claims Database in Japan

​発表年月

Nov-22

Therapeutic area
免疫/膠原病/感染症
Immunology/Infectious disease

549

Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases

​発表年月

Nov-22

Therapeutic area
免疫/膠原病/感染症
Immunology/Infectious disease

547

The Long-Term Healthcare Utilization and Economic Burden of RSV Infection in Children ≤5 Years in Japan: Propensity Score Matched Cohort Study

​発表年月

Nov-22

Therapeutic area
免疫/膠原病/感染症
Immunology/Infectious disease
小児科
Pediatrics

546

Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data

​発表年月

Nov-22

Therapeutic area
免疫/膠原病/感染症
Immunology/Infectious disease
bottom of page